Caso, V.M.; Sperlongano, S.; Liccardo, B.; Romeo, E.; Padula, S.; Arenga, F.; D’Andrea, A.; Caso, P.; Golino, P.; Nigro, G.;
et al. The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy. J. Clin. Med. 2022, 11, 475.
https://doi.org/10.3390/jcm11030475
AMA Style
Caso VM, Sperlongano S, Liccardo B, Romeo E, Padula S, Arenga F, D’Andrea A, Caso P, Golino P, Nigro G,
et al. The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy. Journal of Clinical Medicine. 2022; 11(3):475.
https://doi.org/10.3390/jcm11030475
Chicago/Turabian Style
Caso, Valentina Maria, Simona Sperlongano, Biagio Liccardo, Emanuele Romeo, Sergio Padula, Fortunato Arenga, Antonello D’Andrea, Pio Caso, Paolo Golino, Gerardo Nigro,
and et al. 2022. "The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy" Journal of Clinical Medicine 11, no. 3: 475.
https://doi.org/10.3390/jcm11030475
APA Style
Caso, V. M., Sperlongano, S., Liccardo, B., Romeo, E., Padula, S., Arenga, F., D’Andrea, A., Caso, P., Golino, P., Nigro, G., & Russo, V.
(2022). The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy. Journal of Clinical Medicine, 11(3), 475.
https://doi.org/10.3390/jcm11030475
